CHASSITY JONES: Open Payments
NPI 1952889859 · MADISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,513 in 166 payments from 50 companies in 2025. Trend: 2023 $1,285 · 2024 $3,674 · 2025 $4,513
Food & beverage: $4,259Education: $254
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $438 |
| AstraZeneca Pharmaceuticals LP | 16 | $395 |
| Novartis Pharmaceuticals Corporation | 13 | $363 |
| Janssen Biotech, Inc. | 7 | $292 |
| Merck Sharp & Dohme LLC | 10 | $286 |
| JAZZ PHARMACEUTICALS INC. | 4 | $186 |
| Eisai Inc. | 7 | $166 |
| Incyte Corporation | 7 | $149 |
| GENZYME CORPORATION | 4 | $116 |
| Genentech USA, Inc. | 6 | $115 |
Products named: Enhertu, RYBREVANT, KEYTRUDA, KISQALI, Lenvima, CALQUENCE, SCEMBLIX, ZIIHERA.
Industry payments across TN — which companies pay providers there.
